Human nutrition

University of Western States Celebrates 120 Years of Excellence in Chiropractic and Whole-Person Health Care Education

Retrieved on: 
Thursday, March 21, 2024
Sentinel, Health, Chiropractic education, Functional medicine, Organization, University, System, Learning, Veteran, Partnership, Education, Patient, School, Athlete, Student, Human nutrition, Council, Person, University of Western States, Licensure, Sentinel Hotel, Development, Trustee, Life University, Sports medicine, Nursing

PORTLAND, Ore., March 21, 2024 /PRNewswire/ -- This year University of Western States (UWS) celebrates the 120th anniversary of its founding, marking over a century of advancing chiropractic medicine and whole-person health education.

Key Points: 
  • PORTLAND, Ore., March 21, 2024 /PRNewswire/ -- This year University of Western States (UWS) celebrates the 120th anniversary of its founding, marking over a century of advancing chiropractic medicine and whole-person health education.
  • This legacy of academic excellence continues to evolve as UWS shapes the future of whole-person health care and education."
  • Since its founding in 1904, University of Western States has been at the forefront of innovation and leadership in chiropractic care and hosts the longest-established Doctor of Chiropractic degree program in the Western United States.
  • As University of Western States commemorates its 120th anniversary, the university community looks forward to preparing the next generation of whole-person health care professionals to serve the evolving needs of a diverse and dynamic world.

Dr. Ernst J. Schaefer, MD, joins Olaris Inc. as CLIA Laboratory Director

Retrieved on: 
Tuesday, March 5, 2024
Human nutrition, Bangladesh Technical Education Board, Ageing, Research, American Heart Association, Cardiovascular disease, Metabolomics, Health, Tufts University, Society, University, Health care, Medicine, Fluid mechanics, Policy, CLIA, Patient, Machine learning, Nutrition, Publication, Tufts Medical Center, Medical device

FRAMINGHAM, Mass., March 5, 2024 /PRNewswire-PRWeb/ -- Olaris, Inc., a precision medicine company leveraging metabolomics and machine learning for the discovery and development of its myOLARIS™ diagnostics products, announced that Dr. Ernst Schaefer, a 30-year veteran in clinical diagnostics and an expert in developing monitoring tools to improve human health will be joining as CLIA Laboratory Director. Dr. Schaefer will continue in his role as laboratory director for Boston Heart Diagnostics, a company he co-founded in 2007, and at Clinical Enterprise, both in Framingham, MA.

Key Points: 
  • Olaris, Inc. a developer of metabolomic based precision diagnostics is pleased to announce that Dr. Ernst Schaefer, a 30 year veteran in clinical diagnostics and an expert in developing monitoring tools to improve human health will be joining as CLIA Laboratory Director.
  • Dr. Schaefer will continue in his role as laboratory director for Boston Heart Diagnostics, a company he co-founded in 2007, and at Clinical Enterprise, both in Framingham, MA.
  • "Ernie has one of the top clinical diagnostic minds in the world" said Dr. Elizabeth O'Day, CEO and Founder of Olaris.
  • I can't think of a better partner to bring Olaris' innovative diagnostics to the patients that need them".

Balchem Corporation Reports Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Friday, February 16, 2024
CFO, Human nutrition, Animal nutrition, Mineral, ID, Food, GAAP, Nutrient, Public expenditure

Financial Results for the Fourth Quarter of 2023:

Key Points: 
  • Financial Results for the Fourth Quarter of 2023:
    The Human Nutrition & Health segment generated fourth quarter sales of $138.0 million, an increase of $7.6 million or 5.8% compared to the prior year quarter.
  • The Animal Nutrition & Health segment generated quarterly sales of $58.2 million, a decrease of $6.6 million or 10.2% compared to the prior year quarter.
  • I am excited about our future.”
    A quarterly conference call will be held on Friday, February 16, 2024, at 11:00 AM Eastern Time (ET) to review fourth quarter 2023 results.
  • Balchem Corporation reports three business segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.

Metabolic Health Trends: The Future of Balanced Wellness, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Tuesday, January 30, 2024
World Health Organization, Health, Diet, Science, Human nutrition, Nutrient, Specialization, Doctor of Philosophy, Metabolism, Master of Science, Exercise, Overweight, ADM, Dietary supplement

TORONTO, Jan. 30, 2024 /PRNewswire-PRWeb/ -- Discover an informative webinar to explore shifting metabolic health trends, uncovering science-backed insights on wellness. The idea of health and what it means to be healthy has evolved significantly over the years. What was once assessed through standalone measurements is increasingly being viewed from a holistic outlook. Metabolic health, which is comprised of five key health markers, offers a comprehensive look at an individual's overall health state and, because of this, is proving to be a better predictor of long-term wellness.

Key Points: 
  • Attendees will gain insights into the specific indicators of metabolic health and their keen importance to well-being.
  • Attendees will learn about science-backed ingredients for dietary supplement solutions targeted to support the various aspects of metabolic health.
  • TORONTO, Jan. 30, 2024 /PRNewswire-PRWeb/ -- Discover an informative webinar to explore shifting metabolic health trends, uncovering science-backed insights on wellness.
  • Join this webinar to learn about trends in metabolic health and formulating products that incorporate science-backed microbiome solutions and functional botanical ingredients.

Balchem Corporation Reports Third Quarter Sales of $229.9 Million, with Net Earnings of $29.1 Million, GAAP EPS of $0.90, and Adjusted EPS of $1.04

Retrieved on: 
Friday, October 27, 2023
Human nutrition, Food, Public expenditure, GAAP, Acquisition, Animal nutrition, Calumet Specialty Products Partners, ID, Bergstrom, Mineral, CFO, Nutrient, Bank, Pharmaceutical industry, Music

Financial Results for the Third Quarter of 2023:

Key Points: 
  • Financial Results for the Third Quarter of 2023:
    The Human Nutrition & Health segment generated record quarterly sales of $144.5 million, an increase of $1.8 million, or 1.3%, compared to the prior year quarter.
  • The Animal Nutrition & Health segment generated quarterly sales of $53.9 million, a decrease of $11.7 million, or 17.8%, compared to the prior year quarter.
  • Ted Harris said, “The Balchem team delivered another solid quarter, once again, highlighting the strength and resilience of our business model.
  • Sales and production of products outside of our reportable segments and other minor business activities are included in "Other and Unallocated".

EQS-News: Alzchem Group AG significantly increases EBITDA by 19.8% to EUR 56.3 million in the nine-month period 2023

Retrieved on: 
Thursday, October 26, 2023
Human nutrition, Crop protection, Intermediate 1, EBITDA, Growth, Basics, EUR, Speciality chemicals, Investment, Fine chemical, Lithium, Agriculture

EUR 80 million, sales stable at previous year’s level

Key Points: 
  • EUR 80 million, sales stable at previous year’s level
    Trostberg, October 26, 2023 – Alzchem Group AG, a vertically integrated specialty chemicals supplier with a leading market position in selected niche markets, successfully held its ground in the first nine months of 2023.
  • Despite a slight decline in sales of 2.7% from EUR 409.0 million to EUR 397.9 million, all key earnings figures were increased.
  • Despite the slight decline in sales and continued cost pressure, Alzchem achieved EBITDA of EUR 56.3 million, equivalent to growth of 19.8%.
  • It is projected to grow strongly from EUR 61.4 million to approximately EUR 80 million.

ADM Reports Third Quarter Earnings per Share of $1.52, $1.63 on an Adjusted Basis

Retrieved on: 
Tuesday, October 24, 2023
Food, Beverage, Manufacturing, Environment, Retail, Food Tech, Other Science, Sustainability, Supply Chain Management, Fitness & Nutrition, Science, Technology, Other Natural Resources, Biotechnology, Agriculture, Natural Resources, Health, Chemicals, Plastics, Agritech, Human nutrition, Insurance, Sale, ADM, Ethanol, Meat, Dicarboxylic acid, Vegetable oil, Starch, Acquisition, Animal nutrition, Segment, International, Hurricane Ida, EPS, Risk management, Sugar substitute, Webcast, Association of Jewish Aging Services, Business, Central Time, Wellness, Video game, Pharmaceutical industry, Financial services, Corporation

South American origination results were higher year-over-year, as the team delivered significantly higher volumes and margins on strong export demand.

Key Points: 
  • South American origination results were higher year-over-year, as the team delivered significantly higher volumes and margins on strong export demand.
  • Effective risk management and higher volumes and margins in Global Trade led to strong results, however, lower year-over-year.
  • In the quarter, there were large net positive mark-to-market timing effects, which were lower than the net positive impacts in the prior year quarter.
  • Other Business results were significantly higher than the prior-year quarter due to improved ADM Investor Services earnings on higher net interest income.

Balchem Corporation Reports Second Quarter Sales of $231.3 Million, with Net Earnings of $30.1 Million, GAAP EPS of $0.93, and Adjusted EPS of $1.06

Retrieved on: 
Friday, July 28, 2023
Mineral, Food, Animal nutrition, Nutrient, GAAP, ID, Public expenditure, Calumet Specialty Products Partners, Human nutrition, Kappa, Bergstrom, CFO, Bank, Real estate, Pharmaceutical industry

Financial Results for the Second Quarter of 2023:

Key Points: 
  • Financial Results for the Second Quarter of 2023:
    The Human Nutrition & Health segment generated quarterly sales of $135.7 million, an increase of $4.0 million, or 3.1%, compared to the prior year quarter.
  • The Animal Nutrition & Health segment generated quarterly sales of $61.3 million, a decrease of $1.3 million, or 2.0%, compared to the prior year quarter.
  • The decrease was driven by lower sales in monogastric markets, partially offset by higher sales in the ruminant species markets.
  • Sales and production of products outside of our reportable segments and other minor business activities are included in "Other and Unallocated."

ADM Reports Second Quarter Earnings per Share of $1.70, $1.89 on an Adjusted Basis

Retrieved on: 
Tuesday, July 25, 2023
Food, Beverage, Manufacturing, Environment, Retail, Food Tech, Other Science, Sustainability, Supply Chain Management, Fitness & Nutrition, Science, Technology, Other Natural Resources, Biotechnology, Agriculture, Natural Resources, Health, Chemicals, Plastics, Agritech, Sugar substitute, ADM, Nutrition, Wellness, Ethanol, Segment, Association of Jewish Aging Services, Wilmar, Business, Risk management, Animal nutrition, Central Time, Dicarboxylic acid, Sale, Human nutrition, Destination marketing organization, Webcast, EPS, Vegetable oil, Meat, International, Starch, Insurance, Financial services, Flour, Fertilizer, Fine chemical, Q2, Corporation

Crushing results were much lower than the record result from the second quarter last year.

Key Points: 
  • Crushing results were much lower than the record result from the second quarter last year.
  • Refined Products and Other results were significantly higher than the prior-year period, achieving a record second quarter.
  • Human Nutrition results were in-line with the second quarter of 2022, as the team effectively managed a challenging demand environment.
  • Other Business results were significantly higher than the prior-year quarter due to improved ADM Investor Services earnings on higher net interest income.

Balchem Corporation Reports Record First Quarter Sales of $232.5 Million, with Net Earnings of $22.7 Million, GAAP EPS of $0.70, and Adjusted EPS of $0.94

Retrieved on: 
Friday, April 28, 2023
Mineral, Food, Animal nutrition, Nutrient, GAAP, ID, Public expenditure, Calumet Specialty Products Partners, Human nutrition, Kappa, EBITDA, Bergstrom, CFO, Growth, Bank, Video game

Sequentially, compared with the fourth quarter of 2022, sales increased 1.7% in the first quarter of 2023 and adjusted earnings from operations increased 14.1%.

Key Points: 
  • Sequentially, compared with the fourth quarter of 2022, sales increased 1.7% in the first quarter of 2023 and adjusted earnings from operations increased 14.1%.
  • The Animal Nutrition & Health segment generated quarterly sales of $64.9 million, a decrease of $4.5 million, or 6.4%, compared to the prior year quarter.
  • Sequentially, compared with the fourth quarter of 2022, sales and adjusted earnings were essentially flat in the first quarter of 2023.
  • Sequentially, compared with the fourth quarter of 2022, sales increased 1.3% in the first quarter of 2023 and adjusted earnings from operations were essentially flat.